Announcements

24 January 2025
Acknowledgment to the Reviewers of Antioxidants in 2024


The editorial team at Antioxidants extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Antioxidants received 7650 review reports from 3245 reviewers representing 54 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Antioxidants expresses its sincere gratitude through an annual acknowledgment of reviewers. As a further token of appreciation, all reviewers are eligible for the Outstanding Reviewer Award, which honors their essential role in enhancing the quality of our publications.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

Astrida Velena

Georgios Papadopoulos

Michael Appell

Abdul Rashid Aziz

Gerald Audette

Michael Schirmer

Abraham Wall-Medrano

Gertrude Emilia Costin

Michael Sticherling

Achilleas George Mitrakas

Gheorghe Solcan

Michal Nowicki

Ádám Juhász

Giampiero Cai

Michele Tonelli

Adam Matkowski

Gian Marco Ghiggeri

Miguel A. Medina-Morales

Adela Pintea

Gianluca Viscusi

Miguel Alcaraz

Adele Papetti

Gianni Paulis

Miguel Ángel García-Sánchez

Adelina Vlad

Gilles Lemaître

Miguel Hueso

Adina Ionuta Gavrila

Gina Cecilia Pistol

Miguel Sogorb

Ádina Santana

Gina Segovia-Siapco

Mihaela Aida Vasile

Adolfo Andrade-Cetto

Giovanni Casini

Mihaela Beregoi

Adrian Gericke

Giovanni Levi

Mihaela Niculae

Adriana Cristina Urcan

Giovanni Tarantino

Mihail Mitov

Adriana Elena Bulboacă

Gisela Beutner

Mikko Laukkanen

Adriana Paucean

Gisela F. Erf

Mingxin Shi

Agata Wawrzyńczak

Giulia Abate

Minseok Song

Agnes Farkas

Giulia Squillacioti

Miriam A. Hickey

Agnieszka Ewa Wiącek

Giuliano Tocci

Mirosława Chwil

Agnieszka Gniazdowska-Piekarska

Giuseppe Bruschetta

Mohd Farhan

Agnieszka J. Szczepek

Giuseppe Cirillo

Monica Florescu

Agnieszka Szewczyk

Giuseppe Colella

Monica Muratori

Agnieszka Wnuk

Giuseppe Losurdo

Monika Fekete

Agnieszka Zelek-Molik

Glenn Lobo

Murat Basar

Ailton Cesar Lemes

Gloria Salazar

Myron R. Szewczuk

Ala E. Abudabos

Goran Baranović

Nafsika Karakatsouli

Alain Massart

Goran Gajski

Nam Deuk Kim

Alarico Ariani

Grzegorz Bartosz

Nanako Kawaguchi

Alberto Marra

Guan-Jhong Huang

Natale Musso

Alejandra García-Gasca

Guihong Bi

Natalya S. Zinkevich

Aleksandra Czumaj

Guillermo Cristian G. Martínez-Ávila

Nathalie Lalevée

Aleksandra Jaromira Józefczyk

Guillermo López-Lluch

Nathan K. Evanson

Aleksandra Pavićević

Guy Cohen

Nayab Tahir

Alessandra Gianoncelli

Halina Tkaczenko

Neven Papić

Alessandra Pelagalli

Hans Bäumler

Nicholas J. Bradshaw

Alessio Ardizzone

Hao Cheng

Nicola Bernabò

Alessio D’Alessio

Harris Pratsinis

Nicola Marchetti

Alexander Bartelt

Harsh Kumar

Nicola Schiavone

Alexander J. Michels

Hayato Terayama

Nicole Schupp

Alexandr Mikyška

Herbert Ryan Marini

Nicoleta Badea

Alexandra Scholze

Herman J. Woerdenbag

Nikolina Gaćina

Alexandre Lamas

Hernan E. Lara

Nikos Margaritelis

Alexandrina Ferreira Mendes

Heyu Chen

Nobuhiro Aburai

Alexios Vlamis

Hidehisa Shimizu

Oana Cioanca

Alfredo Caturano

Hikaru Hori

Oana Lelia Pop

Alfredo G. Casanova

Hiromichi Ueno

Olha Mykhailenko

Alica Pizent

Hiroyuki Kanzaki

Pádraig D’Arcy

Alicia Maroto

Hiroyuki Kataoka

Pamela Maher

Alicja Józkowicz

Hiroyuki Kinoshita

Panagiotis Mallis

Alicja Kluczyk

Holger Martens

Panagiotis Simitzis

Ama-Tawiah Essilfie

Holger Steinbrenner

Panagiotis Theodosis-Nobelos

Amelia Silva

Hongmin Wang

Paola Di Pietro

Amit K. Jaiswal

Hossein Akbari Aghdam

Paola Giussani

Amparo Chafer

Howard Boudreau

Parisa Gazerani

Amritlal Mandal

Hsinjung Ho

Pascal Amireault

Ana Amić

Huai Deng

Pascal Pineau

Ana I. Rey

Hugo Espinosa Andrews

Patrizio Tremonte

Ana Isabel Beltrán-Velasco

Hui Sun

Paul Witting

Ana Margarida Passos Borges

Humberto González-Rios

Paula Silva

Ana Maria de Lauro Castrucci

Hyun-Tai Lee

Paulo Santos

Ana Muñoz-Jurado

Ibukunoluwa Fola Olawuyi

Pedro Fernandes

Ana Petelin

Igor Jakovcevski

Pedro Robles

Ana Rita Jesus

Igor Piotr Turkiewicz

Pedro Sousa Sampaio

Anaberta Cardador-Martínez

Ildiko Szanto

Pedro Tauler

Anapaula Sommer Vinagre

Ileana Farcasanu

Petar Ozretić

Anca Dinischiotu

Iliyan Ivanov Ivanov

Petru Alexandru Vlaicu

Anca Toiu

Imran Ali Lakhiar

Photini V. Mylona

André Baby

Inaki Elio

Pierluigi Diotaiuti

Andrea Ambrosini-Spaltro

Ines Drenjancevic

Pierre Tennstedt

Andrea Baschieri

Ioannis Kanakis

Pieter-Jan A. M. van Ooij

Andrea Brancaccio

Ioannis Konstantinos Karabagias

Pinelopi Samara

Andrea Deledda

Irena Budić-Leto

Piotr Michel

Andrea Maria Patelski

Irina Balan

Po-Wen Chen

Andrea Silvestrini

Isabella Panfoli

Qian Wang

Andrei Ivanov

Isabella Russo

Qiang Peng

Andreia C. M. Rodrigues

Ismael Aranda

Qiu Li

Andrew Povey

István Egerszegi

Qiuyun Xu

Andy T. Y. Lau

Iuliana Aprodu

Radu Ciprian Racovita

Anelia Iantcheva

Iuliana Mihaela Deleanu

Rafael Salto

Aneta Ostróżka-Cieślik

Ivana Leščić Ašler

Rafał Filip

Angel Campa

Iveta Bernatova

Rafał Frański

Angel Josabad Alonso-Castro

Iza F. Pérez-Ramírez

Raffaele Pellegrino

Ángel Juan García Yagüe

Jacinta Pinho

Rahul Kumar

Angel Llamas

Jae-kyu Ryu

Rahul Mittal

Angela Bisio

Jaime Arellanes-Robledo

Rais Ansari

Angela Stufano

Jalil Ghassemi Nejad

Rajaram Rajamohan

Angélica Villarruel-López

James Arthur Maclean

Rajkumar Vutukuri

Angeliki Chroni

James D. West

Ralf Blank

Anirban Das

James W. Navalta

Raluca Nicu

Anita M. Kelly

Jan Udala

Rami Salim Najjar

Anna Bilska-Wilkosz

Jan Winkler

Ramóna Pap

Anna Korus

Janakiraman Udaiyappan

Ranjha Khan

Anna Rafaela Cavalcante Braga

Janos Filep

Raquel P. F. Guiné

Annalaura Brai

Janusz Madaj

Rebecca Creamer

Annamaria Perna

Jaroslaw Korus

Rekha Jagadapillai

Anthony Rowe

Jarosław Leon Przybył

Renata Walczak-Jędrzejowska

Anton Kováčik

Jason P. Chua

René Huber

Antonella D'Anneo

Javier Caballero-Villarraso

Reni Kalfin

Antonella Maria Aresta

Javier German Rodriguez Carpena

Rhitajit Sarkar

Antonella Rosa

Jayanta Kumar Patra

Riccardo Amorati

Antoni Pons

Jean Albert Boutin

Richard Bright

Antonio Mincione

Jean-Claude Desfontis

Richard Naftalin

Ariana Saraiva

Jean-Marc Zingg

Rita Santos Inácio

Arijit Nath

Jean-Paul Jay-Gerin

Ritesh Srivastava

Arjun H. Banskota

Jeni Prosperi

Robert A. Linsenmeier

Arlei Coldebella

Jennifer Gubitosa

Robert Burghardt

Armando Caseiro

Jennifer Richard

Robert Eibl

Armida Sánchez-Escalante

Jérôme D. Robin

Robert Kleszcz

Arrigo Cicero

Jerzy Bełtowski

Robert Pełech

Andromachi Tzani

Iulia Varzaru

Robert Steven Esworthy

Asuncion Rocher

Jesús Palá-Paúl

Robert Tyler

Atefeh Najafi

Jinle Xiang

Roberta Imperatore

Athanasia Varvaresou

Jinwei Zhang

Roberta Prete

Athanasios A. Panagiotopoulos

Joachim M. Weitzel

Roberto Castiglione

Athanasios C. Kimbaris

Joana Madureira

Roberto Fabiani

Athina Angelopoulou

Joana Prata

Roberto Palacios-Ramirez

Atish Mukherji

Joan-Lluis Vives Corrons

Roberto Romaniello

Atsuki Nara

Joanna Beata Bierła

Robin Cooper

Aviva Levina

João Paulo Capela

Rocío Castro Ríos

Azizur Rahman

João Simões

Rocio Salceda

Barbara Ciastek

Joaquim Carreras

Rodica Margaoan

Barbara Illi

Joaquim Esteves da Silva

Rodica Mihaela Dinica

Barbara Jadach

John Carragher

Rodrigo Valenzuela

Barbara Shukitt-Hale

Jorge Feito

Roland Wohlgemuth

Bárbara Teixeira

José A. Sánchez-Alcázar

Rolffy Ortiz-Andrade

Beata Zadykowicz

José Agustín Tapia Hernández

Ronaldo Thomatieli-Santos

Beatrice Paradiso

Jose Alberto Gallegos-Infante

Ronan Padraic Murphy

Beppe Benedetto Consentino

José Artur Brito

Rosa María Oliart-Ros

Bernard A. Hauser

José C. J. M. D. S. Menezes

Rosalba Troncoso-Rojas

Bernd Kaina

Jose Coelho

Rosanna Avola

Bhola S. Pradhan

José Enrique O'Connor

Rosanna Mallamaci

Bice Avallone

Jose Juan Buenrostro Figueroa

Rosie Yagmur Yegin

Bijay P. Chhetri

Jose M. Mulet

Roxana Liana Lucaciu

Bin Wang

José Manuel Benito

Rudian Zhang

Blanca Herrera

José Ramiro Afonso Fernandes

Rui M. S. Cruz

Bo Ram Lee

Jose Ramon Acosta Motos

Rumiana Tzoneva

Bo Sun

Jose Tudela

Ruoyu Mao

Bo Wang

Joseph Cullen

Ruth Schwalbe

Boel De Paepe

Joshua D. Klein

Ryota Hosomi

Bogdan Sevastre

Juan Francisco Leon

Sachio Takeno

Boldeanu Mihail Virgil

Juan Mozas-Moreno

Salah Amasheh

Brendan Duggan

Juan Wang

Salvatore Valiante

Brent Siesky

Juan-Carlos Galvez-Ruiz

Samson Oyeyinka

Bulmaro Cisneros

Judit Oláh

Sanda Andrei

  1. Michael Greenlief

Julio Ochoa

Sanda Maria Cretoiu

Cale D. Fahrenholtz

Julio Plaza-Diaz

Sanda Win

Camelia Sorina Stancu

Julita Kulbacka

Sandipan Datta

Carlo Cosentino

Jun Kobayashi

Sandra Ghelardoni

Carlos López-de-Celis

Jun Liu

Sandra L. Mcfadden

Carmen L. Del Toro-Sánchez

Jun-Gyu Park

Sangho Koo

Carmen López-Sánchez

Jyoti Bala Kaushal

Sanjay Anand

Catherine C. Neto

Kamila Rybczyńska-Tkaczyk

Santiago Pedro Aubourg Martínez

Catherine Yzydorczyk

Kamyar Zahedi

Sara C. Zapico

Chang Liu

Kan Katayama

Sara Castro-Barquero

Chang Shu

Karel Allegaert

Sara Massironi

Changseon Ryu

Kari Stone

Sara Spinelli

Chang-Wei Hsieh

Karl J. A. McCullagh

Sarabjit Mastana

Changwon Yang

Karolina Pycia

Sarita Lagalwar

Chao-Hui Feng

Karsten Grote

Sascha Rohn

Chao-Kai Chang

Katalin Sipos

Sayed K. Goda

Charalabos Kanakis

Katerina Chlichlia

Selva Rivas

Charles E. Norton

Katia Comte

Selvakumar Subbian

Chen Dong

Katsuya Kitamura

Serge P. Bottari

Chieh-Chih Tsai

Kazuchika Nishitsuji

Serkos Haroutounian

Chih-Li Lin

Kazuhiko Nakadate

Seyed Khosrow Tayebati

Chika Saegusa

Ke Liu

Shahab Mirshahvaladi

Christian Ralf Gernhardt

Keisuke Ishizawa

Shaoling Lin

Christie Ying Kei Lung

Keith Rochfort

Shaoxing Dai

Christina Banti

Ken Shirato

Shifeng Pan

Christine Hellweg

Ken-Ichi Aihara

Shima Momen

Christoph Hudemann

Kenneth N. White

Shinji Takamatsu

Christophe Furger

Kenneth Olson

Shuen-Ei Chen

Christopher J. Martyniuk

Kielan Mcalinden

Shunsuke Sakakibara

Chuang-Rung Chang

Kijin Kim

Shuya Kasai

Chun Guo

Kinga Musiał

Sicong Wang

Chung-Hsin Wu

Kit-Leong Cheong

Sílvia A. Sousa

Clara Naccari

Ko Fujimori

Silvia Dossena

Claudio Caprari

Koji Sakamoto

Silvia Maribel Contreras-Ramos

Clementina Sansone

Konrad Andrzej Szychowski

Simona Bartimoccia

Codruta Soica

Konstantinos Palikaras

Simone Brogi

Consolato M. Sergi

Kosuke Nishi

Simone de Brot

Constantin Munteanu

Kristina Kantminienė

Simonetta Cristina Di Simone

Constantinos Giaginis

Kristina Pilipović

Sing-Chung Li

Constanza Cárdenas Carvajal

Kristina Ramanauskiene

Siyan Cao

Corneliu Tanase

Krystian Mokrzyński

Sneha S. Pillai

Costanza Maria Cristiani

Krzysztof Krysta

Snježana Kaštelan

Crisalejandra Rivera-Perez

Kun Qiao

Socorro Retana-Marquez

Cristian Sandoval

Kuo-Hui Su

Sofija Andjelic

Cristiane Casagrande Denardin

Kyeong Soo Kim

Sonia Benítez

Cristiano José de Andrade

Kyung Mok Park

Sophia Hatziantoniou

Cristina Alexandra Almeida Aguiar

Kyyoung Park

Sophia Letsiou

Cristina Bettencourt Neves

Labusca Lăbușcă

Sorana D. Bolboacă

Cristina Mihaela Ghiciuc

Lakshmaiah Sreerama

Sotirios Kalfas

Cristina Pinedo

Lance Keller

Spyridon Kintzios

Cristina Sgherri

Lasse Lindahl

Spyridon Mourtas

Cristobal Miranda

Laszlo Biczok

Stănciuc Nicoleta

Cyril Fersing

Laura Bardi

Stanisław Kalisz

Damiano Cavallini

Laura Grațiela Vicaș

Stanislawa Bazan-Socha

Daniel Bäcker

Laura Rizzi

Stefano Bacci

Daniel Hernandez-Patlan

Laura Vicente

Sten Andreasson

Daniel José Barbosa

Laurence Dedeken

Stepan Gambaryan

Daniel Potaczek

Laurent Metzinger

Stephan Krähenbühl

Daniel Souza Monteiro de Araujo

Leao Martins José Manuel

Stéphane Betoulle

Daniela Braconi

Lee J. Martin

Stephen Randall

Daniela Elena Serban

Lei Di

Stephen Walker

Daniela Vieira Buchaim

Leilane R. B. Dourado

Supandeep Singh Hallan

Daniele Bani

Leilson Rocha Bezerra

Susana Rocha

Daniele Vergara

Leopold Eckhart

Suzanne M. De La Monte

Dariel Tovar-Ramirez

Lesław Juszczak

Sylwia Zielinska

Dariusz Dziki

Li Xiao

Szymon Sip

Dariusz Jedrejek

Lidia Montero

Tadeusz Hryniewicz

Dariusz Kokoszyński

Lidija Milkovic

Taiki Miyazawa

Darren Lipnicki

Lih-Geeng Chen

Takehisa Hanawa

David Allan Butterfield

Lin-Fu Liang

Takujiro Homma

David Beversdorf

Lisardo Boscá

Talha Bin Emran

David Greenhalgh

Lola Llobat

Tamás Letoha

David J. Ramsey

Longgang Wang

Tanya Camacho

David Pei-Cheng Lin

Loredana Bergandi

Tanya Ivanova Topouzova-Hristova

David R. P. Almeida

Lorena Duca

Tatiana Carlesso Santos

Davide Piccinino

Lorenzo Tassi

Tatiana Kostrominova

Deanne H. Hryciw

Loris Pinto

Tatsuo Shimosawa

Debasish Bandyopadhyay

Lubos Cipak

Thatyane Fonteles

Debora Levy

Lucia Marcocci

Theodoros Varzakas

Defeng Xu

Lucia Rocco

Thomas Greither

Dejiang Ni

Lucia Stanciakova

Thomas L. Broderick

Denglei Ma

Lucian Hritcu

Tiago Duarte

Denisa Margina

Luciana Bordin

Tianyu Hou

Deokho Lee

Luciano Pirola

Timothy Artlip

Di Yu

Ludmila Kazdova

Tofani Daniela

Dia C. Beachboard

Luigi di Bitonto

Tomáš Čajka

Diana Pinto

Luigi Donato

Tomasz M. Karpinski

Diego Gabriel Ogando

Luis A. Rubio

Tomasz Tuzimski

Diego Morales

Luis Alberto Gaitán-Cepeda

Tomislav Tosti

Dimitra Toubanaki

Luis Angel Medina-Juárez

Tommaso Lombardi

Dimitrios Gougoulis

Luis Enrique Cobos Puc

Tomohide Takaya

Dimitrios N. Kanakis

Luis G. Sequeda-Castañeda

Tong Zhao

Dimosthenis Kizis

Luís Manuel Lourenço Félix

Torbjörn Ledin

Dong Wook Shin

Luisa Gorza

Toshikazu Suzuki

Dong-Wei Di

Lukasz Dobrek

Triantafyllos Didangelos

Dongyang Zhang

Łukasz Szeleszczuk

Trias Thireou

Don Green

Lyudmila Simova

Tsungcheng Tsai

Dorin Dragoş

  1. H. Mahbub

Tsvetelina Georgieva Batsalova

Dorota Formanowicz

Magdalena Frańska

Tyler W. Lebaron

Dritan Siliqi

Magdalena Górnicka

Ulf Anderegg

Duo Zhang

Magdalena Lebiedzinska-Arciszewska

Vajir Malek

Edgar R. López-Mena

Magdalena Martinez-Cañamero

Valdir Florencio Veiga-Junior

Eduardo Ansorena

Mahtab Nourbakhsh

Valentina Sancisi

Eduardo Padilla-Camberos

Maja Jazvinšćak Jembrek

Valentina Vellecco

Eduardo Rivadeneyra Domínguez

Makoto Tsunoda

Valeria Maria Morittu

Edward N. Harris

Malcolm Jobling

Valerie Amarger

Eiichiro Nagata

Małgorzata Duda

Valério Monteiro-Neto

Eijiro Akasaka

Małgorzata Gniewosz

Vance Nielsen

Eisuke Amiya

Małgorzata Jeleń

Vanja Milija Tadić

Eleftheria Hatzidaki

Malgorzata Nowacka

Vasantha Padmanabhan

Elena Falqué

Manfred Neuberger

Vasia Mavrogianni

Elena Grossini

Mansour Sobeh

Vasiliki Fadouloglou

Elena Zocchi

Manuela Lanzafame

Vassilis Athanasiadis

Eleuterio A. Sánchez Romero

Marc Herb

Vassilis Demopoulos

Elijah W. Stommel

Marcel Henrique Marcondes Sari

Vehary Artavazd Sakanyan

Elisa Cairrao

Marcella Nebbioso

Vera M. Chesnokova

Elisabetta Genovese

Marcelo Barros

Verónica Bastos

Elisavet Bouloumpasi

Marcelo Nicolas Muscara

Vidhya R. Rao

Elitza P. Markova-Car

Marcin Barszcz

Viktor Brygadyrenko

Eloy Bejarano Fernandez

Marcin Lukasiewicz

Vinayak Khodade

Elsa Ching H. Chan

Marco Albano

Vincenzo Summa

Emanuele-Salvatore Scarpa

Marco Biagi

Violeta-Carolina Niculescu

Emerson Venancio

Marco Corazzari

Volker Boehm

Emilia Janiszewska-Turak

Marco Govoni

Volkhard Helms

Emilie Erin Vomhof-DeKrey

Marcus Mareel

Wanda Mączka

Enrico Santangelo

Marek Sebela

Weihua Huang

Enrique Herrera-López

Marek Wesolowski

Wenceslao Valenzuela-Quiñónez

Enrique Rico-García

Margareta Törnqvist

Wenchao Yang

Enzo Martegani

Maria Addolorata Bonifacio

Wenji Piao

Eric Ruelland

Maria Carmela Bonaccorsi di Patti

Wing Shing Ho

Eric S. Peeples

Maria Concetta Scuto

Wladimir Bocca Vieira de Rezende Pinto

Erick Nuñez-Vazquez

María D. Navarro-Hortal

Wojciech Koch

Erick Paul Gutiérrez-Grijalva

Maria Dolores Mauricio

Wolfram Kunz

Erika Cione

Maria Elisa Drago-Serrano

Wonbeak Yoo

Ernő Zádor

Maria Iorizzi

Xavier Gallart-Palau

Eros Di Giorgio

Maria Iskra

Xiangfei Li

Essam Ahmed Ghazaly Kerwash

María Muriach

Xiangyu Guo

Ester Trigueros Andrés

María Orosia Lucha-López

Xiaojuan Liu

Eugenio Velasco-Ortega

Maria P. Monsalve Pérez

Xiaolong Ji

Eva Latorre

Maria P. Tsantarliotou

Xi-Ming Yuan

Evan Stubbs

Maria Pia Ferraz

Xiong Xiong

Evangelia Vouvoudi

Maria Roulia

Xisheng Li

Ewa Chrzescijanska

María Teresa Tejedor

Xuelin Zhou

Ewa M. Urbanska

Mariaanna Argentou

Yang Liu

Fábio Rodrigues Ferreira Seiva

María-José Argente

Yang-Wei Lin

Fabio Sciubba

Mariana Chelu

Yangyang Liu

Fatima Cerqueira

Marie-Odile Benoit-Biancamano

Yanka Dimitrova Karamalakova

Felipe Leite Oliveira

Marijn M. Speeckaert

Yara T. E. Lechanteur

Fengzhi Li

Marina Garcia-Macia

Yasumasa Okazaki

Fernanda Mesquita

Marina Paolucci

Ye Liu

Filippo Rossi

Marina Villalon Mir

Yolanda Leticia López-Franco

Filomena Fezza

Mario Dell'Agli

Yong Jin

Flavia Pichiorri

Marisol Orozco-Ibarra

Yong-Moon Lee

Flavia Zacconi

Mariusz Niemczyk

Yongqiang Chen

Flávio Figueira

Mariusz Siemiński

Yongsheng Chen

Flore Depeint

Mark Mitchell

Yong-Xin Liu

Fougere Laëtitia

Mark R. Miller

Yoshinari Uehara

Francesca Aiello

Marta Gaburjáková

Youlu Yuan

Francesca Cencetti

Marta Llansola

Young Zoon Kim

Francesca Lionetto

Marta Tsirigotis-Maniecka

Yuliang Wei

Francesca Sciandra

Martha Rocio Moreno Jimenez

Yung-Hsiang Chen

Francesco Giuseppe Martire

Martin Cerny

Yunhong Li

Francesco Pallotti

Martin Gierus

Yushun Yang

Francisco Guillen-Grima

Marvin A. Soriano-Ursúa

Yuta Sugiyama

Francisco J. Del Castillo

Massimiliano Meli

Yutian Zou

Francisco Javier Olivas-Aguirre

Massimo Venditti

Yuya Kumagai

Francisco Lázaro-Diéguez

Matias Monsalves-Álvarez

Yves Combarnous

Francisco Pradas de la Fuente

Matteo Becatti

Zaki A. Sherif

Francisco Rubén Badenes-Pérez

Matteo Bonetti

Zdenka Ďuračková

Francisco Solano

Matteo Conti

Zehuan Liao

Frank Erdmann

Matteo Dell’Anno

Željko Jakšić

Gábor Katona

Matthias Eckhardt

Zhen Chen

Gabriela Rapeanu

Maurits K. A. van Selms

Zhengrong Yuan

Gabriella Saviano

Maurizio Mandala

Zhengwei Huang

Gaetano Marverti

Maurizio Mulas

Zhengyuan Su

Gareth Morgan

Maurizio Sabbatini

Zhibin Liu

Gary Caldwell

Mauro Lombardo

Zhide Ding

Ge Tao

Maximilian Lackner

Zhidong Zhou

Gederts Ievinsh

Mei Yu

Zhong Jian

Geert Potters

Melville B. Vaughan

Zhongqi He

George Imataka

Meng-Tsan Chiang

Zhongyang Ren

Georgina Sandoval

Mercedes Fernandez

Zoltán Kukor

Georgios Pampalakis

Mercedes Villacampa

Zygmunt Warzecha

21 January 2025
MDPI’s Newly Launched Journals in December 2024

Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)


Prof. Dr. Zhaoyang Dong
City University of Hong Kong, China
Editorial | View inaugural issue

energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage
View journal scope | Submit an article

Prof. Dr. Yang-Hui He
1. London Institute for Mathematical Sciences, Royal Institution, UK
2. University of Oxford, UK
Editorial | View inaugural issue
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory;  convex geometry
View journal scope | Submit an article

Dr. Michel Planat
Université de Franche-Comté, France
Editorial | View inaugural issue
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets
View journal scope | Submit an article

Prof. Dr. Rashid Al Abri
1. Sultan Qaboos University, Oman
2. Oman Medical Association, Oman
Editorial | View inaugural issue
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety
View journal scope | Submit an article

Prof. Dr. Ecevit Bilgili*
New Jersey Institute of Technology, USA
*Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration.
Editorial | View inaugural issue
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production
View journal scope | Submit an article

Dr. Weiyong Liu
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry
View journal scope | Submit an article

Prof. Dr. Manuel Pedro Rodríguez Bolívar
University of Granada, Spain
Editorial | View inaugural issue
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation
View journal scope | Submit an article

Prof. Dr. Fei Fan
Wuhan University, Wuhan 430072, China
Editorial | View inaugural issue
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice
View journal scope | Submit an article

Dr. Kevin Cianfaglione
Université Catholique de Lille, France
Editorial | View inaugural issue
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation
View journal scope | Submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

17 January 2025
Meet Us at the 145th Annual Meeting of the Pharmaceutical Society of Japan, 26–29 March 2025, Fukuoka, Japan


Conference:
The 145th Annual Meeting of the Pharmaceutical Society of Japan
Date: 26–29 March 2025
Location: Fukuoka, Japan

MDPI will be attending the 145th Annual Meeting of the Pharmaceutical Society of Japan as an exhibitor, which will be held from 26 to 29 March 2025, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.

The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: 1) Pharmaceutical Chemistry; 2) Pharmaceutical Physics; 3) Pharmaceutical Biology; 4) Pharmaceutical Health Science and Environmental Toxicology; 5) Pharmaceutical Health Care and Sciences; and 6) Others.

The following MDPI journals will be represented at the conference:

  • Biomedicines
  • Pharmaceuticals
  • Pharmaceutics
  • Antibiotics
  • Antibodies
  • Antioxidants
  • CIMB
  • Diseases
  • Future Pharmacology
  • IJERPH
  • IJMS
  • IJTM
  • JNT
  • JPM
  • Marine Drugs
  • Medicina
  • Medicines
  • Metabolites
  • Psychoactives
  • Sci. Pharm
  • Sclerosis

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://pub.confit.atlas.jp/en/event/pharm145.

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

7 January 2025
Meet Us at the 12th International Conference on Nutrition and Growth, 20–22 February 2025, Athens, Greece


MDPI will be attending the 12th International Conference on Nutrition and Growth, which will be held from 20 to 22 February 2025 in Athens, Greece. This conference will be the ultimate meeting place to discuss the interplay between nutrition and growth in the pediatric age-group. The field of nutrition and growth in child development continues to evolve, and we invite you to join us in uncovering new knowledge, discussing the latest data, exploring challenges and best practices, and sharing ideas and perspectives between different disciplines in order to facilitate collaborations.

The following MDPI journals will be represented at the symposium:

If you are planning to attend the above conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have.

For more information about the conference, please visit the official website at https://nutrition-growth.kenes.com/.

20 December 2024
Antioxidants | Issue Cover Articles in 2024

The articles below have been selected as 2024 Issue Cover Articles by the Editorial Office of Antioxidants (ISSN: 2076-3921). These articles came from multiple fields within the scope of Antioxidants, and we hope they can provide insights and references for scholars in related fields.

1. “Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress”
by Xenia Abadin, Cristina de Dios, Marlene Zubillaga, Elia Ivars, Margalida Puigròs, Montserrat Marí, Albert Morales, Marisa Vizuete, Javier Vitorica, Ramon Trullas et al.
Antioxidants 2024, 13(12), 1440; https://doi.org/10.3390/antiox13121440
Available online: https://www.mdpi.com/2076-3921/13/12/1440

2. “Mutations Selectively Evolving Peroxidase Activity Among Alternative Catalytic Functions of Human Glutathione Transferase P1-1”
by  Aram Ismail and Bengt Mannervik
Antioxidants 2024, 13(11), 1347; https://doi.org/10.3390/antiox13111347
Available online: https://www.mdpi.com/2076-3921/13/11/1347

3. “The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology”
by Hugo Fanlo-Ucar, Pol Picón-Pagès, Víctor Herrera-Fernández, Gerard ILL-Raga and Francisco J. Muñoz
Antioxidants 2024, 13(10), 1208; https://doi.org/10.3390/antiox13101208
Available online: https://www.mdpi.com/2076-3921/13/10/1208

4. “Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia”
by Ignacio Silva-Llanes, Raquel Martín-Baquero, Alicia Berrojo-Armisen, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz, Eva De Lago and Isabel Lastres-Becker
Antioxidants 2024, 13(9), 1072; https://doi.org/10.3390/antiox13091072
Available online: https://www.mdpi.com/2076-3921/13/9/1072

5. “Activation of Nuclear Factor Erythroid 2-Related Factor 2 Transcriptionally Upregulates Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Expression and Inhibits Ectopic Calcification in Mice
by Ida Tomomi, Hiroyuki Kanzaki, Miho Shimoyama, Syunnosuke Tohyama, Misao Ishikawa, Yuta Katsumata, Chihiro Arai, Satoshi Wada, Shugo Manase and Hiroshi Tomonari
Antioxidants 2024, 13(8), 896; https://doi.org/10.3390/antiox13080896
Available online: https://www.mdpi.com/2076-3921/13/8/896

6. “Mitigating Dietary Microplastic Accumulation and Oxidative Stress Response in European Seabass (Dicentrarchus labrax) Juveniles Using a Natural Microencapsulated Antioxidant”
by Matteo Zarantoniello, Nico Cattaneo, Federico Conti, Margherita Carrino, Gloriana Cardinaletti, İdris Şener and Ike Olivotto
Antioxidants 2024, 13(7), 812; https://doi.org/10.3390/antiox13070812
Available online: https://www.mdpi.com/2076-3921/13/7/812

7. “Nitric Oxide Binding Geometry in Heme-Proteins: Relevance for Signal Transduction”
by Giovanna De Simone, Alessandra di Masi, Diego Sbardella, Paolo Ascenzi and Massimiliano Coletta
Antioxidants 2024, 13(6), 666; https://doi.org/10.3390/antiox13060666
Available online: https://www.mdpi.com/2076-3921/13/6/666

8. “Unravelling the Role of Candida albicans Prn1 in the Oxidative Stress Response through a Proteomics Approach
by Victor Arribas, Lucia Monteoliva, María Luisa Hernáez, Concha Gil and Gloria Molero
Antioxidants 2024, 13(5), 527; https://doi.org/10.3390/antiox13050527
Available online: https://www.mdpi.com/2076-3921/13/5/527

9. “Redox Regulation of Mitochondrial Potassium Channels Activity”
by Joanna Lewandowska, Barbara Kalenik, Antoni Wrzosek and Adam Szewczyk
Antioxidants 2024, 13(4), 434; https://doi.org/10.3390/antiox13040434
Available online: https://www.mdpi.com/2076-3921/13/4/434

10. “Multifaceted Effects of L-Cysteine, L-Ascorbic Acid, and Their Derivatives on the Viability and Melanin Synthesis of B16/F10 Cells under Different Conditions”
by Joon Yong Choi, Jae Won Ha and Yong Chool Boo
Antioxidants 2024, 13(3), 330; https://doi.org/10.3390/antiox13030330
Available online: https://www.mdpi.com/2076-3921/13/3/330

11. “Evaluation of the Shelf life of Ready-to-Eat Fresh Bamboo Sprouts (Phyllostachys edulis) Packaged in a Modified Atmosphere or Vacuum: A Comparative Study”
by Vincenzo Sicari, Rosa Tundis, Rosa Romeo, Antonella Reitano, Emilia Lucia Belsito, Antonella Leggio and Monica Rosa Loizzo
Antioxidants 2024, 13(2), 185; https://doi.org/10.3390/antiox13020185
Available online: https://www.mdpi.com/2076-3921/13/2/185

12. “Heavy Metal Exposure: Molecular Pathways, Clinical Implications, and Protective Strategies”
by Hajime Koyama, Teru Kamogashira and Tatsuya Yamasoba
Antioxidants 2024, 13(1), 76; https://doi.org/10.3390/antiox13010076
Available online: https://www.mdpi.com/2076-3921/13/1/76

19 December 2024
Interview with Dr. Namgyu Lee—Winner of the Antioxidants 2023 Young Investigator Award

We recently interviewed the winner of the Antioxidants Young Investigator Award 2023, Dr. Namgyu Lee, an assistant professor in the Department of Biomedical Science & Systems Biology at Dankook University, South Korea. Her paper in Antioxidants (ISSN: 2076-3921) received the 2023 Best Paper Award for its high citation rate.

Dr. Namgyu Lee shared what qualities a young scientist needs and her suggestions for young researchers who are just starting out in the field:

17 December 2024
Over 100 German Universities Partner with MDPI in New National Agreement


More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated by ZB MED comes into effect on 1 January 2025 and is valid until the end of 2026. Joining the consortium is still possible until the beginning of 2025. We are delighted by the high level of interest this agreement has already garnered, reflecting the strong demand for accessible and cost-effective open access publishing solutions among German research institutions.

This new cooperation aims to make scientific gold open access publishing more affordable and less administratively burdensome for researchers in Germany. The agreement includes substantial discounts on article processing charges (APCs) for corresponding authors from participating institutions. It offers flexible payment options, including centralized invoicing or individual payment of fees by researchers or their institutions. Additionally, the agreement features a flat-fee model that enables institutions to precisely plan expenses and optimize their library budgets.

"MDPI can look back on over a decade of successful partnerships with German research institutions," says Peter Roth, MDPI Head of Publishing. "The new agreement marks another milestone in the long-standing co-operation between MDPI and the German scientific community. It emphasizes our commitment to developing up-to-date and inventive solutions for the diverse needs of scientific institutions to promote open research for the benefit of researchers."

Petra Labriga, Head of Strategic License Management at ZB MED, highlighted the agreement's significance: "As one of the world's leading Gold OA publishers, MDPI plays a central role in the German publishing landscape. We are particularly pleased that we were able to achieve considerable potential cost savings for scientific institutions and their authors at a national level through our negotiations."

The partnership reflects a common goal of advancing the idea of open access and supporting researchers in making their scientific excellence internationally visible.

"We would like to thank the ZB MED consortium team for their excellent collaboration," added Adrian Stefan Zamfir, MDPI Institutional Partnership Manager for the DACH region. "We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform."

Franziska Fischer (right), Commercial Director at ZB MED, an Peter Roth (left), Head of Publishing at MDPI, celebrate the signing of the new national open access agreement between MDPI and the ZB MED Consortium.

Peter Roth (center) joined ZB MED's Lea Carolina Schindler, Petra Labriga, Franziska Fischer, and Jonathan Lehmann in Cologne, Germany, on 13 December 2024 to sign the agreement.

More Information

  • Conditions and participation opportunities (German): Link
  • Frequently asked questions (German): Link

Contact


About ZB MED

ZB MED - Information Centre for Life Sciences is an infrastructure and research centre for life science information and data. Its aim is to support and strengthen research for people and the environment: from medicine to biodiversity and environmental protection.

The work of ZB MED is orientated towards the strategic guidelines:

  • Research + Networking: We conduct research together with the regionally, nationally, European and globally networked research community.
  • Data science: We enable data analyses and generate new knowledge through research.
  • Access to information: We provide sustainable access to information, literature and data as a central information infrastructure.
  • Open + FAIR: We promote open and reproducible science in line with open science and FAIR principles.
  • Knowledge and skills transfer: We actively impart knowledge, competences and skills.

More information at www.zbmed.de.

About MDPI

Headquartered in Basel, Switzerland, MDPI is one of the world's leading open access publishers with a current portfolio of more than 440 journals in all scientific disciplines. MDPI‘s goal is to advance open science worldwide through greater transparency, efficiency and collaboration. To date, more than 3.7 million researchers have published their results in MDPI journals. The editorial process is overseen by a large network of dedicated reviewers and editors and supported by more than 6500 MDPI employees. MDPI currently works with over 800 academic institutions and 180 scientific societies worldwide, which benefit from a wide range of MDPI services and products.

17 December 2024
Article Layout and Template Revised for Future Volumes

We are pleased to announce a series of updates to our template, aimed at improving the readability and overall aesthetics of our publications. These changes have been meticulously designed to enhance the user experience and ensure consistency across all our publications. The updated template will be available for download from the Instructions for Authors page.

The following updates will be applied to articles published in the 2025 volumes, starting on 24 December 2024:

  • Main text: The line spacing has been increased to improve the readability of publications;
  • Header and footer: The link to the journal website will be removed, as a hyperlink has been integrated into the journal logo. Additionally, the DOI link will be moved from the left-hand side to the right-hand side, and both the header and footer will be slightly raised to achieve a better balance;
  • Left information bar: The information provided here has been rearranged for better organization; the CC-BY logo will be removed;
  • Font size: The font size used for the abstract, keywords, and first-level headings will be increased.

Furthermore, MDPI journals will continue to use article numbers. This approach enables us to maintain a rapid and efficient production process by being able to define pagination as soon as a paper is accepted.

We hope that the new version of the template will provide users with a better experience and make the process more convenient.

Please contact production@mdpi.com if you have any questions or suggestions.

6 December 2024
MDPI INSIGHTS: The CEO's Letter #18 - MDPI UK, Basel Job Fair, CETEF'24

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s First UK Summit Held in Manchester

On 29 November, we hosted our first annual MDPI UK Summit, bringing together over 30 Chief Editors and Editorial Board Members (EBMs) to discuss MDPI’s mission, achievements, and collaborations in the UK.

Throughout the day we had talks from several members of MDPI, roundtable discussions on the peer-review process and upholding research integrity, and an engaging presentation from the Editor-in-Chief (EiC) of MDPI journal Mathematics, Francisco Chiclana, about his involvement with the Research Excellence Framework.

“This was a great first summit for MDPI UK and received excellent feedback”

 In the following I highlight some of the sessions and the discussion topics covered in each session.

Session 1: Opening Speech and Introduction to MDPI

I shared an overview of MDPI’s mission, achievements, and commitment to quality. The Q&A touched on key topics such as perception and reputation management, expanding our arts and humanities portfolio, and funding challenges for open access (OA) in the UK.

A takeaway from this session was that in 2025, we will circulate a mini annual report to all editors, helping them understand MDPI’s mission and achievements beyond the context of their specific journals.

Session 2: MDPI and the Research Excellence Framework (REF)
Prof. Francisco Chiclana (EiC of Mathematics) highlighted MDPI’s role in REF, its purpose, and future directions.

Session 3: Editorial Process, Ethics, and Research Integrity
Dr. Giulia Stefenelli presented on the various editorial roles and responsibilities, quality metrics, and procedures for dealing with misconduct. The Q&A centred on AI in publishing, institutional roles in research integrity, and better data management practices.

Session 4: Institutional Open Access Program (IOAP)
Becky Castellon presented on IOAP benefits, including MDPI’s partnership with JISC, which includes more than 60 UK institutions, and highlighted the advantages of pure OA over transformative agreements.

Session 5: Round Table Discussion
Colleagues from our MDPI Manchester office Jaime Anderson and Dr. Michael O’Sullivan, along with colleagues from our Basel office Damaris Critchlow and Giulia Stefenelli, discussed innovations in peer review, challenges in maintaining scientific integrity, and future solutions.

Session 6: MDPI PR and the Voice of the Customer
I recapped our customer satisfaction drivers, including speed and editorial support. I also spoke about tackling misinformation about OA and MDPI in general, and outlined a way forward for us all to participate in advocating for open science.

This was a great first summit for MDPI UK and received excellent feedback from our EiCs, SEiCs, and EBMs. A BIG thank-you to our Manchester team (pictured below) and everyone else involved in organizing this event. Their hard work and dedication are much appreciated!

Impactful Research

MDPI and UK Publications

The UK is an important market for MDPI, ranking ninth in total submissions to MDPI and eighth in total MDPI publications, with over 72,200 publications to date. As at October 2024, there were more than 3,600 EBMs from the UK, 48% of whom have an H-index above 26. We also have 46 EiCs, and 63 SEiCs in the UK, some of whom joined us in Manchester for the UK Summit.

The UK is a strong advocate of OA publishing, with nearly three quarters of all articles in 2023 published on open access platforms. The country enjoys a large academic market, producing high-quality papers, and is home to some of the world’s top universities. Among MDPI’s 825 IOAP agreements, over 60 of these are in the UK, facilitated through our partnership with JISC.

“The UK is a strong advocate of OA publishing”

 Visit to MDPI’s Manchester Office

Last week, I visited our Manchester office to see the expanding office space, connect with our staff, and present at the MDPI UK Summit held in Manchester.

Throughout the day, I met with various teams to better understand their work and discuss their future development plans in greater depth. Hearing from group leads about the progress we have made and the challenges we face offered many valuable insights. I also had the chance to connect personally with members of the content team. It’s great to see how this young and ambitious team is coming together.

I also took the opportunity to address the entire office about the role of MDPI UK within the wider company. During this session, I answered questions about growth and public relations initiatives. Giulia Stefenelli joined us to address questions about the role of AI in MDPI’s future.

Jaime Anderson (Office Manager) and the Manchester team have done a great job of growing the office since its establishment in 2019. Today, it has around 150 staff members across various departments, including English editing, editorial services, marketing and communications, and IOAP. The team is highly active in local marketing initiatives, such as author training sessions, scholar visits, and conferences.

For more information and updates on our Manchester office, follow MDPI UK on LinkedIn.

Inside MDPI

Basel Job Fair

In November, the HR team from our Basel office connected with over 300 young professionals at the Basel Job Fair 2024. This is my biased opinion, of course, but we had the best branded booth and merchandise, which drew a lot of attention from young talent wanting to learn about current and future job opportunities at MDPI.

Our HR team also helped review CVs on the spot, providing advice on how to improve them and making a positive impression on the future workforce in Basel.

This is a reminder that MDPI is not only focused on supporting young researchers but that we also recruit and develop young talent. We have seen MDPI HR do this really well throughout all of our offices, from Asia Pacific to Europe and North America.

HR plays an important role in our growing company, helping us meet our recruitment targets as well as providing support for local teams, guidance on management and best practices, a safe space for employees, and brand recognition for MDPI, among many other things.

“MDPI is not only focused on supporting young researchers: we also recruit and develop young talent”

This is a quick appreciation post to all HR staff working to support MDPI and our colleagues, cultivating talent and supporting careers at every stage. Thanks HR staff, keep up the great work!

Coming Together for Science

Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life (The 20th Anniversary)

I am pleased to share that the Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life took place from 27 to 29 November 2024 in Barcelona, Spain. It was chaired by Prof. Dr. Amelia Pilar Rauter from the Universidade de Lisboa, Portugal; Dr. Alfredo Berzal Herranz from Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain; and Prof. Dr. Mary Jane Meegan from Trinity College Dublin, Ireland.

The conference took place in Casa Convalescència, a part of the Sant Pau Art Nouveau Site. The three-day event included three plenary sessions and eight invited speakers, from eight countries, and 29 selected talks. Of the presentations on site, there were 32 posters and 29 oral presentations.

The main goal of the ‘Pharmaceuticals 2024’ international conference was to cover the newest technologies and research areas including medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, in a meeting that brought together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to mention just a few of the topics that were discussed.

“The main goal of ‘Pharmaceuticals 2024’ was to cover the newest technologies and research areas”

20th Anniversary of Pharmaceuticals

The year 2024 marks the 20th anniversary of Pharmaceuticals – a journal dedicated to medicinal chemistry and related drug sciences, which is published monthly online by MDPI. To honour this milestone, we are reflecting on our past accomplishments and embarking on an exciting new chapter. This celebration is also one of the reasons why we organized the conference Pharmaceuticals 2024. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. Pharmaceuticals has published over 6,000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed for it at least once.

20th Anniversary of Pharmaceuticals: The Video

This video captures the experiences of the conference chairs, honorary guests and committee members of the conference.

 

Thank you to our partnering societies

A special thank-you is due to our partnering societies the Spanish Society Of Medicinal Chemistry (SEQT) and the Spanish Society For Biochemistry And Molecular Biology (SEBBM) for their support of the Pharmaceuticals 2024 conference. I am also pleased to report that we presented two awards, sponsored by the journal Pharmaceuticals, including the Best Presentation Award and the Best Oral Presentation Award, recognizing the contributions of our participants.

Closing Thoughts

Presenting at the 4th Central European Technology Forum

I visited Krakow, Poland in November to participate in the 4th Central European Technology Forum (CETEF’24), which took place on 18 and 19 November.

CETEF is an international conference that has been jointly organized since 2014 by the Polish Chamber of Commerce for Advanced Technologies (IZTECH) and the Polish Federation of Engineering Associations, with the support of the European Parliament and the European Commission, in cooperation with universities, research institutes and the high-tech industry. The 2024 event focused on presentation to advance the European science and technology agenda for 2025–2030.

MDPI participated as a key publishing sponsor. We had an exhibition booth and held two key presentations during the conference. On Monday, I presented MDPI’s vision, purpose, and achievements.

On Tuesday, Dr. Giulia Stefenelli shared how MDPI supports advancements in high technology and energy transition, highlighting our portfolio, services, tools and initiatives for promoting progress and interdisciplinary collaboration.

We received positive feedback from scientists and government representatives in attendance.

A big thank-you goes to our colleagues from the Krakow office for their support in organizing our participation and managing the MDPI booth.

Special thanks are owing to Weronika Gorka-Kumik, Igor Matic, Vincent Di, Agnieszka Rydz, Ksenia Shubenkova, Anna Krakowka and Klaudia Kasprowicz.

Below is a photo with the President of the Polish Chamber of Commerce conference (centre), along with MDPI colleagues Giulia Stefenelli, Weronika Gorka-Kumik, and Igor Matic (left to right).

“This year’s event focused on ideas and proposals to advance the European science and technology agenda for 2025–2030”

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop